OCGN

Conviction 28HealthcareScan · Mon, Aug 10, 2026

OCGN$1.31+2.34%

ResistanceSupportVol 14

Vol MA14 5.4M

May 11May 28Jun 16Jul 6Jul 23Aug 10

Ocugen, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.ocugen.com ↗

Price1.31

Change+2.34%

Gap-1.17%

Rel volume2.85×

Avg volume5.27M

Avg $ vol6.8M

SMA 201.29

SMA 501.34

SMA 2001.52

Price vs 50-1.99%

Price vs 200-13.55%

MA stackbearish

50/200 cross—

Supertrenddown · 1.45

RSI (14)50

MACD hist0.01

MACD crossbull · 1d

Stoch %K / %D88 / 60

ADX (14)19

+DI / −DI16 / 21

RSI divergence—

MACD divergence—

ATR %+5.78%

ADR %5.27%

52w high2.48

52w low0.9807

From 52w high-47.18%

Above 52w low+33.58%

New 52w highNo

SqueezeOff

Bollinger width19.81%

%B0.57

Donchian pos45.16%

Donchian high1.48

Donchian low1.17

AVWAP (52w high)1.58

vs AVWAP high-17.32%

AVWAP (52w low)1.60

vs AVWAP low-17.88%

OBV trendDown

Chaikin MF (20)-0.08

Today vs 20d2.85×

Avg vol (14d)5.4M

Avg vol (20d)5.27M

Avg $ vol (20d)6.8M

Market cap444.23M

RS 3m (vs SPY)-16.81%

RS 6m (vs SPY)-17.87%

RS line new highNo

Trend template2/8

Technical rank25.8

1 week+4.80%

1 month-10.88%

3 months-13.25%

6 months-1.50%

1 year+31.00%

YTD-5.07%

P/E-6.55

P/B-26.83

P/S100.67

P/FCF-7.77

EPS-0.2600

Div yield—

ROE409.80%

ROA-54.62%

Debt/Eq-0.11

Current0.80

EV/EBITDA-5.54

Gross margin—

Net margin—

Rev growth8.83%

EPS growth-25.52%

Price target10.25

Target upside682.44%

Analyst ratingBuy

Institutional47.64%

Ent. value345.93M

Revenue1.49M

Net income-24.88M

Gross profit—

Free cash flow-57.15M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out338.52M

Employees116

ListedWed, Dec 3, 2014

Free float298.14M

Float %95.5%

Short interest100.59M

Days to cover18.9d

Short volume39.3%

Squeeze score80 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.07 vs −$0.05

Last surprise-40.0% miss

Setup gradeD

Conviction28 / 100

Pattern quality—

Tech rank25.8 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance1.61

Support1.17

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in OCGN

All disclosures →

No recent disclosed trades by Congress in OCGN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in OCGN

No recent insider (Form 4) filings in OCGN. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in OCGN · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.